Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor

Abstract

Our results demonstrate that TLR2 is an attractive target against metastasis and that targeting immunosuppressive microenvironment using anti-TLR2 antibody is a novel therapeutic strategy for combating a life-threatening metastasis.